Brain Oxygen Perfusion and Oxidative Stress Biomarkers in Fetuses with Congenital Heart Disease—A Retrospective, Case-Control Pilot Study

Fetuses with congenital heart disease (CHD) have circulatory changes that may lead to predictable blood flow disturbances that may affect normal brain development. Hypoxemia and hypoperfusion may alter the redox balance leading to oxidative stress (OS), that can be assessed measuring stable end-prod...

Full description

Bibliographic Details
Main Authors: Maria C. Escobar-Diaz, Miriam Pérez-Cruz, Miguel Arráez, Mari-Merce Cascant-Vilaplana, Abel Albiach-Delgado, Julia Kuligowski, Máximo Vento, Narcis Masoller, Maria Dolores Gómez-Roig, Olga Gómez, Joan Sanchez-de-Toledo, Marta Camprubí-Camprubí
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/11/2/299
_version_ 1827657462694543360
author Maria C. Escobar-Diaz
Miriam Pérez-Cruz
Miguel Arráez
Mari-Merce Cascant-Vilaplana
Abel Albiach-Delgado
Julia Kuligowski
Máximo Vento
Narcis Masoller
Maria Dolores Gómez-Roig
Olga Gómez
Joan Sanchez-de-Toledo
Marta Camprubí-Camprubí
author_facet Maria C. Escobar-Diaz
Miriam Pérez-Cruz
Miguel Arráez
Mari-Merce Cascant-Vilaplana
Abel Albiach-Delgado
Julia Kuligowski
Máximo Vento
Narcis Masoller
Maria Dolores Gómez-Roig
Olga Gómez
Joan Sanchez-de-Toledo
Marta Camprubí-Camprubí
author_sort Maria C. Escobar-Diaz
collection DOAJ
description Fetuses with congenital heart disease (CHD) have circulatory changes that may lead to predictable blood flow disturbances that may affect normal brain development. Hypoxemia and hypoperfusion may alter the redox balance leading to oxidative stress (OS), that can be assessed measuring stable end-products. OS biomarkers (OSB) were measured in amniotic fluid in fetuses with (<i>n</i> = 41) and without CHD (<i>n</i> = 44) and analyzed according to aortic flow, expected cyanosis after birth, and a CHD classification derived from this. Birth head circumference (HC) was used as a neurodevelopment biomarker. CHD fetuses had higher levels of ortho-Tyrosine (o-Tyr) than controls (<i>p</i> = 0.0003). There were no differences in o-Tyr levels considering aortic flow obstruction (<i>p</i> = 0.617). Fetuses with expected extreme cyanosis presented the highest levels of o-Tyr (<i>p</i> = 0.003). Among groups of CHD, fetuses without aortic obstruction and extreme cyanosis had the highest levels of o-Tyr (<i>p</i> = 0.005). CHD patients had lower HC than controls (<i>p</i> = 0.023), without correlation with OSB. Patients with HC < 10th percentile, presented high levels of o-Tyr (<i>p</i> = 0.024). Fetuses with CHD showed increased OSB and lower HC when compared to controls, especially those with expected extreme cyanosis. Our results suggest that increased levels of OSB are more influenced by the effect of low oxygenation than by aortic flow obstruction. Future studies with larger sample size are needed to further investigate the role of OSB as an early predictor of neurodevelopmental problems in CHD survivors.
first_indexed 2024-03-09T22:44:30Z
format Article
id doaj.art-62a47127738b41e497c709b789b65a82
institution Directory Open Access Journal
issn 2076-3921
language English
last_indexed 2024-03-09T22:44:30Z
publishDate 2022-01-01
publisher MDPI AG
record_format Article
series Antioxidants
spelling doaj.art-62a47127738b41e497c709b789b65a822023-11-23T18:31:35ZengMDPI AGAntioxidants2076-39212022-01-0111229910.3390/antiox11020299Brain Oxygen Perfusion and Oxidative Stress Biomarkers in Fetuses with Congenital Heart Disease—A Retrospective, Case-Control Pilot StudyMaria C. Escobar-Diaz0Miriam Pérez-Cruz1Miguel Arráez2Mari-Merce Cascant-Vilaplana3Abel Albiach-Delgado4Julia Kuligowski5Máximo Vento6Narcis Masoller7Maria Dolores Gómez-Roig8Olga Gómez9Joan Sanchez-de-Toledo10Marta Camprubí-Camprubí11Pediatric Cardiology Department, Sant Joan de Déu Hospital, 08950 Barcelona, SpainSant Joan de Deu Research Institute, 08950 Barcelona, SpainSant Joan de Deu Research Institute, 08950 Barcelona, SpainNeonatal Research Group, Health Research Institute La Fe, 46026 Valencia, SpainNeonatal Research Group, Health Research Institute La Fe, 46026 Valencia, SpainNeonatal Research Group, Health Research Institute La Fe, 46026 Valencia, SpainNeonatal Research Group, Health Research Institute La Fe, 46026 Valencia, SpainBCNatal-Barcelona Center for Maternal Fetal and Neonatal Medicine, Hospital Clínic, Sant Joan de Déu Hospital, 08950 Barcelona, SpainSant Joan de Deu Research Institute, 08950 Barcelona, SpainBCNatal-Barcelona Center for Maternal Fetal and Neonatal Medicine, Hospital Clínic, Sant Joan de Déu Hospital, 08950 Barcelona, SpainPediatric Cardiology Department, Sant Joan de Déu Hospital, 08950 Barcelona, SpainSant Joan de Deu Research Institute, 08950 Barcelona, SpainFetuses with congenital heart disease (CHD) have circulatory changes that may lead to predictable blood flow disturbances that may affect normal brain development. Hypoxemia and hypoperfusion may alter the redox balance leading to oxidative stress (OS), that can be assessed measuring stable end-products. OS biomarkers (OSB) were measured in amniotic fluid in fetuses with (<i>n</i> = 41) and without CHD (<i>n</i> = 44) and analyzed according to aortic flow, expected cyanosis after birth, and a CHD classification derived from this. Birth head circumference (HC) was used as a neurodevelopment biomarker. CHD fetuses had higher levels of ortho-Tyrosine (o-Tyr) than controls (<i>p</i> = 0.0003). There were no differences in o-Tyr levels considering aortic flow obstruction (<i>p</i> = 0.617). Fetuses with expected extreme cyanosis presented the highest levels of o-Tyr (<i>p</i> = 0.003). Among groups of CHD, fetuses without aortic obstruction and extreme cyanosis had the highest levels of o-Tyr (<i>p</i> = 0.005). CHD patients had lower HC than controls (<i>p</i> = 0.023), without correlation with OSB. Patients with HC < 10th percentile, presented high levels of o-Tyr (<i>p</i> = 0.024). Fetuses with CHD showed increased OSB and lower HC when compared to controls, especially those with expected extreme cyanosis. Our results suggest that increased levels of OSB are more influenced by the effect of low oxygenation than by aortic flow obstruction. Future studies with larger sample size are needed to further investigate the role of OSB as an early predictor of neurodevelopmental problems in CHD survivors.https://www.mdpi.com/2076-3921/11/2/299congenital heart diseasehypoxiabrain perfusionreactive oxygen speciesortho-Tyrosineoxidative stress
spellingShingle Maria C. Escobar-Diaz
Miriam Pérez-Cruz
Miguel Arráez
Mari-Merce Cascant-Vilaplana
Abel Albiach-Delgado
Julia Kuligowski
Máximo Vento
Narcis Masoller
Maria Dolores Gómez-Roig
Olga Gómez
Joan Sanchez-de-Toledo
Marta Camprubí-Camprubí
Brain Oxygen Perfusion and Oxidative Stress Biomarkers in Fetuses with Congenital Heart Disease—A Retrospective, Case-Control Pilot Study
Antioxidants
congenital heart disease
hypoxia
brain perfusion
reactive oxygen species
ortho-Tyrosine
oxidative stress
title Brain Oxygen Perfusion and Oxidative Stress Biomarkers in Fetuses with Congenital Heart Disease—A Retrospective, Case-Control Pilot Study
title_full Brain Oxygen Perfusion and Oxidative Stress Biomarkers in Fetuses with Congenital Heart Disease—A Retrospective, Case-Control Pilot Study
title_fullStr Brain Oxygen Perfusion and Oxidative Stress Biomarkers in Fetuses with Congenital Heart Disease—A Retrospective, Case-Control Pilot Study
title_full_unstemmed Brain Oxygen Perfusion and Oxidative Stress Biomarkers in Fetuses with Congenital Heart Disease—A Retrospective, Case-Control Pilot Study
title_short Brain Oxygen Perfusion and Oxidative Stress Biomarkers in Fetuses with Congenital Heart Disease—A Retrospective, Case-Control Pilot Study
title_sort brain oxygen perfusion and oxidative stress biomarkers in fetuses with congenital heart disease a retrospective case control pilot study
topic congenital heart disease
hypoxia
brain perfusion
reactive oxygen species
ortho-Tyrosine
oxidative stress
url https://www.mdpi.com/2076-3921/11/2/299
work_keys_str_mv AT mariacescobardiaz brainoxygenperfusionandoxidativestressbiomarkersinfetuseswithcongenitalheartdiseasearetrospectivecasecontrolpilotstudy
AT miriamperezcruz brainoxygenperfusionandoxidativestressbiomarkersinfetuseswithcongenitalheartdiseasearetrospectivecasecontrolpilotstudy
AT miguelarraez brainoxygenperfusionandoxidativestressbiomarkersinfetuseswithcongenitalheartdiseasearetrospectivecasecontrolpilotstudy
AT marimercecascantvilaplana brainoxygenperfusionandoxidativestressbiomarkersinfetuseswithcongenitalheartdiseasearetrospectivecasecontrolpilotstudy
AT abelalbiachdelgado brainoxygenperfusionandoxidativestressbiomarkersinfetuseswithcongenitalheartdiseasearetrospectivecasecontrolpilotstudy
AT juliakuligowski brainoxygenperfusionandoxidativestressbiomarkersinfetuseswithcongenitalheartdiseasearetrospectivecasecontrolpilotstudy
AT maximovento brainoxygenperfusionandoxidativestressbiomarkersinfetuseswithcongenitalheartdiseasearetrospectivecasecontrolpilotstudy
AT narcismasoller brainoxygenperfusionandoxidativestressbiomarkersinfetuseswithcongenitalheartdiseasearetrospectivecasecontrolpilotstudy
AT mariadoloresgomezroig brainoxygenperfusionandoxidativestressbiomarkersinfetuseswithcongenitalheartdiseasearetrospectivecasecontrolpilotstudy
AT olgagomez brainoxygenperfusionandoxidativestressbiomarkersinfetuseswithcongenitalheartdiseasearetrospectivecasecontrolpilotstudy
AT joansanchezdetoledo brainoxygenperfusionandoxidativestressbiomarkersinfetuseswithcongenitalheartdiseasearetrospectivecasecontrolpilotstudy
AT martacamprubicamprubi brainoxygenperfusionandoxidativestressbiomarkersinfetuseswithcongenitalheartdiseasearetrospectivecasecontrolpilotstudy